BIOMAT Database Logo BIOMAT Database Logo

Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type. 1997

S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Department of Internal Medicine, Geriatrics and Gerontologic Clinic, University of Pavia, Italy.

Spontaneous natural killer (NK) cell activity and NK-induced cytotoxicity after interferon-gamma (IFN-gamma) were measured in healthy elderly subjects and in patients with senile dementia of Alzheimer type (SDAT) and multi-infarct dementia (MID). Normal basal and IFN-gamma-stimulated NK cytotoxicity were found in healthy old subjects and in patients with MID. On the contrary higher NK cytotoxicity after IFN-gamma (650 IU) was demonstrated in SDAT patients than in MID and healthy subjects (p < 0.001). A significant inverse correlation between the percent increase of NK cytotoxicity after IFN-gamma and the Mini Mental State Examination score (p < 0.001) was also demonstrated in patients with SDAT. Our data might suggest a cytokine-dependent mechanism of NK activation in SDAT associated with the neuroimmune hypothesis of the disease.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Natural killer cell activity in patients with dementia of the Alzheimer type.
April 1990, Archives of neurology,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Reduced natural killer cell activity in patients with dementia of the Alzheimer type.
September 1991, Acta neurologica Scandinavica,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon.
March 1983, Biochemical and biophysical research communications,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
[Senile dementia of Alzheimer type].
January 1999, Ryoikibetsu shokogun shirizu,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
[Senile dementia of Alzheimer type].
October 1999, Nihon Ika Daigaku zasshi,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Senile dementia of the Alzheimer type.
November 1983, Annals of neurology,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Senile dementia of the Alzheimer type.
January 1984, Clinical pharmacy,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
[Senile dementia of the Alzheimer type].
September 1981, Revue medicale de la Suisse romande,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
T-cell interferon gamma binding in patients with dementia of the Alzheimer type.
April 1997, Archives of neurology,
S B Solerte, and M Fioravanti, and S Severgnini, and N Pezza, and M Locatelli, and N Cerutti, and F Terenzi, and E Ferrari
Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type.
August 1989, Annals of neurology,
Copied contents to your clipboard!